Evidence map›Paper›PMID 36916711›Full record

ArticleJournal of comparative effectiveness research2023

A value-based budget impact model for dronedarone compared with other rhythm control strategies.

Jennifer Ken-Opurum, Sesha Ss Srinivas, Pratyusha Vadagam, Lang Faith, Seojin Park, Scott Charland, Andrew Revel, Ronald Preblick

Open access · diamondAbstract read
In one paragraph

Article in Journal of comparative effectiveness research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jennifer Ken-OpurumAxtria Inc., Decision Science, Health Economics and Outcomes Research / Real-World Evidence, Berkley Heights, NJ 07922, USA.
Sesha Ss SrinivasAxtria Inc., Decision Science, Health Economics and Outcomes Research / Real-World Evidence, Berkley Heights, NJ 07922, USA.
Pratyusha VadagamAxtria Inc., Decision Science, Health Economics and Outcomes Research / Real-World Evidence, Berkley Heights, NJ 07922, USA.
Lang FaithAxtria Inc., Decision Science, Health Economics and Outcomes Research / Real-World Evidence, Berkley Heights, NJ 07922, USA.
Seojin ParkSanofi US, US General Medicines, Bridgewater, NJ 08807, USA.
Scott CharlandSanofi US, US General Medicines, Bridgewater, NJ 08807, USA.
Andrew RevelSanofi US, US General Medicines, Bridgewater, NJ 08807, USA.
Ronald PreblickSanofi US, US General Medicines, Bridgewater, NJ 08807, USA.
Sanofi (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmiodaroneAtrial FibrillationAnti-Arrhythmia AgentsDronedaroneHumansSotalolAmiodaroneAnti-Arrhythmia AgentsDronedaroneSotalolcardiology/cardiovascularcomparative effectiveness researchhealth economics

Identifiers

PMID36916711
PMCPMC10402749
OpenAlexW4324129907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.